109 related articles for article (PubMed ID: 1470426)
1. Feasibility of fractionating MAG3 cold kit for cost reduction.
Thorson LM; Hung JC; Hollar BS
Nucl Med Commun; 1992 Nov; 13(11):832-7. PubMed ID: 1470426
[TBL] [Abstract][Full Text] [Related]
2. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3.
Hung JC; Thorson LM
Nucl Med Commun; 1995 Mar; 16(3):157-60. PubMed ID: 7770239
[TBL] [Abstract][Full Text] [Related]
3. 99Tcm-MAG3: in vitro stability and in vivo behaviour at different times after preparation.
Millar AM; Wilkinson AG; McAteer E; Best JJ
Nucl Med Commun; 1990 Jun; 11(6):405-12. PubMed ID: 2143569
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Furudate M
Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
[TBL] [Abstract][Full Text] [Related]
5. Testing different storage conditions for (99m)Tc-MAG3 kit: can hot fractioning reduce the cost per unit dose?
Kiratli PO; Salanci BV
J Nucl Med Technol; 2003 Jun; 31(2):74-5. PubMed ID: 12777456
[TBL] [Abstract][Full Text] [Related]
6. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
7. 99Tcm-MAG3: problems with radiochemical purity testing.
Murray T; McKellar K; Owens J; Watson WS; Hilditch TE; Elliott AT
Nucl Med Commun; 2000 Jan; 21(1):71-5. PubMed ID: 10717905
[TBL] [Abstract][Full Text] [Related]
8. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.
Kanazawa T; Shimizu M; Seto H; Kageyama M; Kameda K; Toyoshima S; Tomizawa G; Watanabe N; Inagaki S
Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
11. Preparation of 99Tcm-MAG3: no confirmation that sodium chloride injections from plastic containers affect radiochemical purity.
Millar AM; O'Brien LM
Nucl Med Commun; 1998 May; 19(5):475-7. PubMed ID: 9853337
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three cold kit reconstitution techniques for the reduction of hand radiation dose.
Bogsrud TV; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Aug; 20(8):761-7. PubMed ID: 10451885
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity.
Shattuck LA; Eshima D; Taylor AT; Anderson TL; Graham DL; Latino FA; Payne SE
J Nucl Med; 1994 Feb; 35(2):349-55. PubMed ID: 8295009
[TBL] [Abstract][Full Text] [Related]
14. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
Lerthirunwong C; Cheng KT; Hladik WB
Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
[TBL] [Abstract][Full Text] [Related]
15. Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm.
Qu T; Wang Y; Zhu Z; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2001 Feb; 22(2):203-15. PubMed ID: 11258408
[TBL] [Abstract][Full Text] [Related]
16. 99Tcm-MAG3: a sensitive indicator for evaluating perfusion and rejection of renal transplants.
Oriuchi N; Miyamoto K; Hoshino K; Imai J; Takahashi Y; Sakai S; Shimada A; Endo K
Nucl Med Commun; 1997 May; 18(5):400-4. PubMed ID: 9194080
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
18. Preparation of 99m Tc-MAG3: the effect on radiochemical purity of using sodium chloride injection from plastic ampoules that have been exposed to light.
Beattie LA; O'Brien LM; Waight CC; Homer NZ; Andrew R; Millar AM
Nucl Med Commun; 2008 Jul; 29(7):649-53. PubMed ID: 18528188
[TBL] [Abstract][Full Text] [Related]
19. Secretion of radioactivity in breast milk following administration of 99Tcm-MAG3.
Evans JL; Mountford PJ; Herring AN; Richardson MA
Nucl Med Commun; 1993 Feb; 14(2):108-11. PubMed ID: 8429987
[TBL] [Abstract][Full Text] [Related]
20. A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.
Millar AM
Nucl Med Commun; 1992 May; 13(5):306-11. PubMed ID: 1318530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
